Skip to content
Annika Bansal – Lifestyle
Author:
Bavarian Nordic A/S
Bavarian Nordic Reports Strong First Half 2026 Results
August 21, 2026
Bavarian Nordic Receives European Commission Approval of Mpox/Smallpox Vaccine for Children Aged 2 to Less than 12 Years
August 7, 2026
Bavarian Nordic’s Chikungunya Vaccine Submitted for Regulatory Approval in Brazil
July 13, 2026
Bavarian Nordic Receives Health Canada Approval for Chikungunya Vaccine
June 29, 2026
Bavarian Nordic Secures Additional Government Contract for the Supply of Smallpox/Mpox Vaccine
June 9, 2026